ARCHIVES

Patient Groups Are Focus of New Alliances In a Shift of Cancer Advocacy Agenda

This article is from The Cancer Letter archive.

Vol. 22 No. 22 | May 31, 1996

Download PDF Visit The Full Archive

Related Articles

FDA Allows Firms To Distribute Reprints On Unapproved Uses of Products

January 16, 2009

DCAB Board Okays One Contract Concept, Sends Another Back to Drawing Board

May 22, 1981

Loeb Named ACS President, Eyre President Elect

November 14, 1986

Senate Committee Schedules Hearing for FDA Acting Commissioner von Eschenbach.

July 28, 2006

NCI, DOE Working Out Details Of Converting Portion Of Idaho Facility to Work On BNCT

July 1, 1988

NCI advisors seek comment on clinical trials system, until Jan. 15.

December 10, 2004